Clinical Trial Update: Placebo Controlled, Randomized Safety and Efficacy Study of RC-1291 in Cancer Anorexia/Cachexia [Phase 2]

View source ↗

Summary

A placebo-controlled, randomized Phase 2 study evaluating the safety and efficacy of RC-1291 in cancer cachexia has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer Cachexia

Drugs mentioned

• RC-1291

Snippet

Sponsor: Helsinn Therapeutics (U.S.), Inc | Conditions: Cancer Cachexia | Phase 2 | Status: COMPLETED